The reversible palmitoylation of G proteins and their receptors is involved both in receptor desensitization and in association and disassociation of Gex subunits with the plasma membrane.
Both G protein aL subunits and G-protein-coupled receptors are palmitoylated through thioester linkages to cysteine residues. The receptors, which are intrinsic membrane proteins based on a bundle of seven hydrophobic, membrane-spanning helices, are palmitoylated in their carboxy-terminal cytoplasmic domains, about 12 residues past the end of the seventh helix. Some receptors terminate just after this residue, but others contain extensive carboxy-terminal domains of 150 amino-acid residues or more.
G protein x subunits, which bind GTP and which interact directly with both receptors and effectors, are palmitoylated near their amino termini, usually at residue 3. The most typical mature amino-terminal structure is an N-myristoylated glycine followed by an S-palmitoylated cysteine. These hydrophobic modifications of Got subunits are in addition to the prenylation, usually by a geranylgeranyl thioether, of Gy subunits on the carboxyterminal cysteine methyl ester.
In the case of the G proteins, which do not have notably hydrophobic amino-acid sequences and which bind at the inner surface of the plasma membrane, palmitoylation and other alkylations increase their overall hydrophobicity and promote their attachment to the membrane. For the already hydrophobic receptors, the differential hydrophobicity contributed by a palmitoyl group is trivial. In either case, why has biology chosen alkylation as a way of increasing hydrophobicity rather than the permanent addition of a few more leucine or valine residues? There are at least two answers.
First, palmitoylation may enhance binding to particular proteins rather than just enhancing membrane attachment. Such recognition of specific cellular structures can change the location of receptors or G proteins in cells. The reversibility of the palmitoylation, triggered directly or indirectly by an agonist, raises the even more enticing prospect that the cell can regulate both the relocalization of signaling proteins and their associations with other proteins.
Regulated turnover of receptor palmitoylation
Ever since the palmitoylation of rhodopsin was first observed in 1988 [1] , a small but steady series of papers has described palmitoylation of other G-protein-coupled receptors; nearly all the receptors contain the palmitoylatable cysteine residue after the seventh span. But mutation of this cysteine-generally has subtle, if any, effects. An engineered rhodopsin mutant with no cytoplasmic cysteine residues is functionally wild type when measured in an in vitro reconstituted assay [2] . Similarly, cysteine missense mutants of 13 2 -adrenergic [3] , D 1 dopaminergic [4] and eo2A-adrenergic [5] receptors, which do not become palmitoylated, have all been reported to display unaltered signaling phenotypes when expressed (at fairly high levels) in cultured cells. In another study, a similar cysteine mutation in the 13 2 -adrenergic receptor caused only subtle changes in G-protein coupling [6, 7] .
Two observations by Bouvier and co-workers [3, 4] made receptor palmitoylation more intriguing by linking it to receptor desensitization, which occurs upon the continued exposure of cells to agonists. Desensitization and subsequent resensitization of G-protein-coupled receptors are the result of a complex set of processes. They include receptor phosphorylation by at least two protein kinases, decreased coupling to G protein (probably caused both by phosphorylation and by the binding of inhibitory proteins known as arrestins), receptor endocytosis and degradation, and (frequently) a decrease in new receptor synthesis.
How does palmitoylation fit in with these processes? Mouillac et al. [3] reported that continued exposure of cells to agonist increases the slow, in vivo labeling of 3 2 -adrenergic receptors with [ 3 H]palmitic acid, an observation later confirmed for D 1 receptors [4] . Of even greater interest, a non-palmitoylated mutant receptor (Cys341Gly) displayed several features of desensitization without exposure to agonist. The mutant receptor was active in signaling, but a little less so than the wild type. Unlike the wild-type receptor, however, the mutant was not much uncoupled by continued agonist exposure. The mutant receptor was also more highly phosphorylated than the wild type in the absence of agonist, but was not phosphorylated much further when agonist was added. Similar observations were made for an analogous mutant D 1 receptor [4] .
When these phenomena are put together and some technical inadequacies overlooked, they make a story that links turnover of palmitoyl groups to receptor desensitization. The simplest version of the story is that unstimulated receptor in the plasma membrane is largely palmitoylated. When stimulated by agonist, the receptor not only activates G protein, but also becomes a better substrate for the enzyme palmitoyl-protein thioesterase, which removes palmitoyl groups [8] . Depalmitoylation triggers receptor phosphorylation, consequent uncoupling and (perhaps) later endocytosis. In this scheme, the observed stimulation of labeling with [
3 H]palmitate in response to continued exposure to agonist reflects some part of the resensitization pathway, perhaps that involved. in movement of receptors into or out of endosomes [9] . More detailed speculations can be left to the imagination of the reader. Now for the hard part. So far, it has not been possible to measure receptor palmitoylation. Labeling with [
3 H]palmitate is expensive, inefficient and hard to detect -two-week exposure of fluorographs of gels of immunoprecipitates or affinity-purified receptor is the norm. Further, labeling with [ 3 H]palmitate may reflect increased steady-state palmitoylation, unchanged net palmitoylation combined with rapid turnover, or even a net decrease in palmitoylation if thioesterase activity is high. So far, there are no data that speak (even qualitatively) to the loss of palmitate from prelabeled receptor. Second, it is unclear which population of receptorpalmitoylated or unpalmitoylated -is under observation in assays of signaling, phosphorylation or endocytosis. Last, some receptors lack the palmitoylated cysteine yet undergo the cycle of uncoupling, endocytosis and recovery. Thus, although receptor palmitoylation certainly seems to be involved in modulating sensitivity to agonists, and in very interesting ways, its control and mechanism of action remain open questions for the G-protein signaling community.
Ga subunit palmitoylation and depalmitoylation
Like the receptors that regulate them, G protein subunits also undergo a cycle of depalmitoylation and palmitoylation. G subunits are palmitoylated on a conserved cysteine residue, usually found at position 3 [10, 11] , and palmitoylation enhances Got binding to membranes. A non-palmitoylated mutant of Goot is found primarily in the cytosol, and the analogous Cys3 mutants of Gsot and Gqa, the wild-type forms of which bind more tightly to membranes than does Got, are found in cytosol fractions at least to some extent [12, 13] . This diminished membrane binding may in fact completely account for the diminished signaling activities noted in some of these mutants [13] , because non-palmitoylated Ga subunits are active in vitro. G, Goa and
Gqao are all largely depalmitoylated during purification, as assessed by their abilities to form disulfides either with mastoparans (short receptor-mimetic peptides [14] ) or with another cysteine residue near the carboxyl terminus (T. Higashijima and myself, unpublished data). All, however, remain responsive to receptors and purified Gsoa and Gqoa efficiently activate their respective effector proteins, adenylyl cyclase and phospholipase C-P.
Like receptors, Ga subunits undergo accelerated depalmitoylation and repalmitoylation when they are activated within the cell during signal transduction. The effects of activation on palmitate turnover on Gat are similar whether activation is by receptors, or is the result of covalent modification by cholera toxin (for Gs) or of a mutation that increases the rate of activation by cellular GTP [12, 15, 16] . In the most thorough study to date, Wedegaertner and Bourne [16] have clarified the linkage between the activation and palmitoylation cycles, and have indirectly estimated the stoichiometry of palmitate turnover. First, they found that activation increased the rate of depalmitoylation of Gsot that had been prelabeled with [ 3 H]palmitate. Activation promoted complete removal of [ 3 H]palmitoyl groups. They argue convincingly that the kinetics of labeling and the subcellular localization of G a are consistent with activation-induced depalmitoylation of membrane-bound Gsa. Depalmitoylation allowed the Got to leave the plasma membrane, and repalmitoylation occurred in the cytoplasm. Because both they and Degtyarev et al. [15] had found that a mutation that inhibits dissociation of Gao from GJy also inhibits the palmitate cycle, Wedegaertner and Bourne inferred that dissociation of activated Ga from Gy precedes hydrolysis of the palmitoyl group and that depalmitoylation is the decisive event in releasing Ga from the membrane. This idea is supported by the observation that depalmitoylation of detergent-solubilized Gsoa was inhibited by GJ3y.
The conclusion of this work, assuming that it is confirmed, is that activation-promoted depalmitoylation of Goa subunits causes their slow transfer to the cytosol. Does this mean that the Got subunits activate cytosolic targets while there? Probably not. Although G proteins deactivate slowly, all but the slowest hydrolyze their bound GTP in less than 3 minutes at 37 OC; G s and G i are much faster than this. Thus, by the time much depalmitoylated Ga gets to the cytosol, it is in the inactive, GDP-bound state. The predominant cytosolic species would thus be inactive. Depalmitoylation is more probably involved in long-term regulation of the signaling activity of Ga subunits, perhaps by altering their associations with other important proteins. Results with the Cys 3 mutants are consistent with this idea.
True solubilization of Ga subunits by removal of a palmitoyl anchor may also be an oversimplification. As argued by Resh [17] , the hydrophobicity of a palmitoyl group is insufficient to anchor a protein to a bilayer. The observed release might indicate that palmitoylation is important for binding to another membrane protein, Gpy perhaps. Alternatively, the observed release may only reflect the massive dilution of cytosol that occurs when cells are homogenized. In cells, depalmitoylated Ga may never leave the membrane but only redistribute laterally. The questions that remain are where the depalmitoylated Ga goes, what it does when it gets there and how it gets palmitoylated again and returned to the signaling switchboard.
